As Alcon Shareholders Fight Back, Will Novartis Sweeten Its Merger Offer?
This article was originally published in The Gray Sheet
Executive Summary
Independent Alcon shareholders have been holding out for months for a buyout offer from Novartis that is closer to what the latter firm is paying for the majority of the company